Publications by authors named "Stephan Heijl"

Predicting pathogenicity of missense variants in molecular diagnostics remains a challenge despite the available wealth of data, such as evolutionary information, and the wealth of tools to integrate that data. We describe DeepRank-Mut, a configurable framework designed to extract and learn from physicochemically relevant features of amino acids surrounding missense variants in 3D space. For each variant, various atomic and residue-level features are extracted from its structural environment, including sequence conservation scores of the surrounding amino acids, and stored in multi-channel 3D voxel grids which are then used to train a 3D convolutional neural network (3D-CNN).

View Article and Find Full Text PDF
Article Synopsis
  • Protein truncating variants in genes like ATM and BRCA1 are linked to higher breast cancer risk, but the risks of missense variants remain unclear.
  • A study involving over 59,000 breast cancer cases analyzed the impact of rare missense variants across several genes using advanced prediction techniques and statistical models.
  • The analysis indicated that some missense variants in genes like ATM and BRCA1 could carry risks similar to truncating variants, while CHEK2 showed a different risk profile, and PALB2 variants had minimal association with breast cancer risk.
View Article and Find Full Text PDF

Unlabelled: Heterozygous carriers of germline loss-of-function variants in the tumor suppressor gene checkpoint kinase 2 (CHEK2) are at an increased risk for developing breast and other cancers. While truncating variants in CHEK2 are known to be pathogenic, the interpretation of missense variants of uncertain significance (VUS) is challenging. Consequently, many VUS remain unclassified both functionally and clinically.

View Article and Find Full Text PDF